Oculis Holding AG (OCS) Accumulated Expenses (2021 - 2026)
Oculis Holding AG (OCS) recorded quarterly Accumulated Expenses of $23.5 million in Q1 2026, down 5.89% quarter-over-quarter from $25.0 million in Q4 2025, and up 6.43% on a YoY basis from $22.1 million in Q1 2025.
Oculis Holding AG (OCS) Accumulated Expenses (2021 - 2026) Analysis & Trends
Oculis Holding AG's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $23.5 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 6.43% year-over-year to $23.5 million; the TTM figure through Mar 2026 stood at $23.5 million (up 6.43% YoY), while the FY2025 annual figure was $25.0 million, up 20.26% from the prior year.
- Accumulated Expenses was $23.5 million for Q1 2026 at Oculis Holding AG, down from $25.0 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $25.0 million in Q4 2025 to a low of $6.7 million in Q4 2023.
- Historically, Accumulated Expenses has averaged $16.6 million across 5 years, with a median of $17.0 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses decreased 19.36% in 2023, then surged 209.8% in 2024.
- A 5-year view of Accumulated Expenses shows it stood at $8.3 million in 2022, then declined by 19.36% to $6.7 million in 2023, then soared by 209.8% to $20.8 million in 2024, then rose by 20.26% to $25.0 million in 2025, then retreated by 5.89% to $23.5 million in 2026.
- The last three Accumulated Expenses figures came in at $23.5 million (Q1 2026), $25.0 million (Q4 2025), and $24.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.51 Mn |
| Dec 31, 2025 | 24.98 Mn |
| Sep 30, 2025 | 24.93 Mn |
| Jun 30, 2025 | 24.06 Mn |
| Mar 31, 2025 | 22.09 Mn |
| Dec 31, 2024 | 20.77 Mn |
| Sep 30, 2024 | 16.97 Mn |
| Jun 30, 2024 | 14.11 Mn |
| Mar 31, 2024 | 9.58 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Sep 30, 2023 | 9.83 Mn |
| Jun 30, 2023 | 9.35 Mn |
| Dec 31, 2022 | 8.32 Mn |
| Dec 31, 2021 | 3.30 Mn |